{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:26:57Z","timestamp":1782808017743,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behaviour Research and Therapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.brat.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T16:17:23Z","timestamp":1538669843000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6040-7708","authenticated-orcid":false,"given":"V\u00edtor Soares","family":"Tardelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Pimentel P\u00e1dua do","family":"Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bisaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Marques","family":"Fidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brat.2018.10.002_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2015.12.036","article-title":"A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence","volume":"160","author":"Carroll","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.brat.2018.10.002_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/00952990701301319","article-title":"A perfect platform: Combining contingency management with medications for drug abuse","volume":"33","author":"Carroll","year":"2007","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.brat.2018.10.002_bib3","first-page":"CD007380","article-title":"Psychostimulant drugs for cocaine dependence","volume":"9","author":"Castells","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1016\/j.brat.2018.10.002_bib4","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/npp.2013.143","article-title":"Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers","volume":"38","author":"Comer","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1098-2396(199810)30:2<119::AID-SYN1>3.0.CO;2-F","article-title":"A novel strategy for the treatment of cocaine addiction","volume":"30","author":"Dewey","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.brat.2018.10.002_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/SAR.S50807","article-title":"Clinical potential of methylphenidate in the treatment of cocaine addiction: A review of the current evidence","volume":"6","author":"Dursteler","year":"2015","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"7","key":"10.1016\/j.brat.2018.10.002_bib7","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1360-0443.2011.03771.x","article-title":"Topiramate for the treatment of methamphetamine addiction: A multi-center placebo-controlled trial","volume":"107","author":"Elkashef","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.brat.2018.10.002_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.drugalcdep.2015.04.021","article-title":"Clinician-delivered contingency management increases engagement and attendance in drug and alcohol treatment","volume":"152","author":"Fitzsimons","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.brat.2018.10.002_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbr.2009.11.029","article-title":"Quetiapine blocks cocaine-induced enhancement of brain stimulation reward","volume":"208","author":"Gallo","year":"2010","journal-title":"Behavioural Brain Research"},{"issue":"1","key":"10.1016\/j.brat.2018.10.002_bib10","first-page":"114","article-title":"Individual characteristics and response to Contingency Management treatment for cocaine addiction","volume":"23","author":"Garcia-Fernandez","year":"2011","journal-title":"Psicothema"},{"issue":"3","key":"10.1016\/j.brat.2018.10.002_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.drugalcdep.2003.10.015","article-title":"Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans","volume":"73","author":"Hart","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"1\u20133","key":"10.1016\/j.brat.2018.10.002_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2009.11.023","article-title":"Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence","volume":"109","author":"Heinzerling","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.brat.2018.10.002_bib13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jaba.158","article-title":"Employment-based abstinence reinforcement promotes opiate and cocaine abstinence in out-of-treatment injection drug users","volume":"47","author":"Holtyn","year":"2014","journal-title":"Journal of Applied Behavior Analysis"},{"key":"10.1016\/j.brat.2018.10.002_bib14","article-title":"Antipsychotic medications for cocaine dependence","volume":"3","author":"Indave","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.brat.2018.10.002_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/10550490490512753","article-title":"Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: A randomized clinical trial","volume":"13","author":"Jones","year":"2004","journal-title":"American Journal on Addictions"},{"issue":"4","key":"10.1016\/j.brat.2018.10.002_bib16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.31887\/DCNS.2007.9.4\/pkalivas","article-title":"Cocaine and amphetamine-like psychostimulants: Neurocircuitry and glutamate neuroplasticity","volume":"9","author":"Kalivas","year":"2007","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"1","key":"10.1016\/j.brat.2018.10.002_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2013.06.005","article-title":"Reinforcing integrated psychiatric service attendance in an opioid-agonist program: A randomized and controlled trial","volume":"133","author":"Kidorf","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.brat.2018.10.002_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0376-8716(03)00032-2","article-title":"Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients","volume":"70","author":"Kosten","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.brat.2018.10.002_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10550490500419169","article-title":"Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals","volume":"15","author":"LaRowe","year":"2006","journal-title":"American Journal on Addictions"},{"issue":"6","key":"10.1016\/j.brat.2018.10.002_bib20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","article-title":"Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: A randomized clinical trial","volume":"72","author":"Levin","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"10.1016\/j.brat.2018.10.002_bib21","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/add.13375","article-title":"Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: The cocaine use reduction with buprenorphine (CURB) study","volume":"111","author":"Ling","year":"2016","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1360-0443.2006.01311.x","article-title":"A meta-analysis of voucher-based reinforcement therapy for substance use disorders","volume":"101","author":"Lussier","year":"2006","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/JCP.0000000000000062","article-title":"Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms","volume":"34","author":"Mancino","year":"2014","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.psc.2012.03.012","article-title":"Psychostimulant treatment of cocaine dependence","volume":"35","author":"Mariani","year":"2012","journal-title":"Psychiatric Clinics of North America"},{"issue":"6","key":"10.1016\/j.brat.2018.10.002_bib25","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/sj.npp.1300420","article-title":"Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: Relationship with cocaine-seeking behavior","volume":"29","author":"Martinez","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.brat.2018.10.002_bib26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1037\/0022-006X.66.5.832","article-title":"Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: Main and matching effects","volume":"66","author":"Maude-Griffin","year":"1998","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"5","key":"10.1016\/j.brat.2018.10.002_bib27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1037\/adb0000192","article-title":"Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: A randomized controlled trial","volume":"30","author":"Miguel","year":"2016","journal-title":"Psychology of Addictive Behaviors"},{"issue":"3","key":"10.1016\/j.brat.2018.10.002_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00952990701313686","article-title":"Citalopram combined with behavioral therapy reduces cocaine use: A double-blind, placebo-controlled trial","volume":"33","author":"Moeller","year":"2007","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"1\u20132","key":"10.1016\/j.brat.2018.10.002_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2008.10.016","article-title":"Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial","volume":"101","author":"Mooney","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.brat.2018.10.002_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2015.12.004","article-title":"Modafinil and sleep architecture in an inpatient-outpatient treatment study of cocaine dependence","volume":"160","author":"Morgan","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nn798","article-title":"Social dominance in monkeys: Dopamine D2 receptors and cocaine self-administration","volume":"5","author":"Morgan","year":"2002","journal-title":"Nature Neuroscience"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nn.2250","article-title":"N-Acetylcysteine reverses cocaine-induced metaplasticity","volume":"12","author":"Moussawi","year":"2009","journal-title":"Nature Neuroscience"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drugalcdep.2005.01.007","article-title":"Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients","volume":"79","author":"Oliveto","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.brat.2018.10.002_bib34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1037\/a0032499","article-title":"Contingency management treatments decrease psychiatric symptoms","volume":"81","author":"Petry","year":"2013","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1037\/a0026883","article-title":"A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients","volume":"80","author":"Petry","year":"2012","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1037\/0022-006X.68.2.250","article-title":"Give them prizes, and they will come: Contingency management for treatment of alcohol dependence","volume":"68","author":"Petry","year":"2000","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"3","key":"10.1016\/j.brat.2018.10.002_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.2003.00642.x","article-title":"Prize reinforcement contingency management for treating cocaine users: How low can we go, and with whom?","volume":"99","author":"Petry","year":"2004","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archpsyc.63.2.219","article-title":"Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population","volume":"63","author":"Poling","year":"2006","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1016\/j.brat.2018.10.002_bib39","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1360-0443.2006.01581.x","article-title":"Contingency management for treatment of substance use disorders: A meta-analysis","volume":"101","author":"Prendergast","year":"2006","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.brat.2018.10.002_bib40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/1874473711205040006","article-title":"Efficacy of contingency management for cocaine dependence treatment: A review of the evidence","volume":"5","author":"Schierenberg","year":"2012","journal-title":"Current Drug Abuse Reviews"},{"key":"10.1016\/j.brat.2018.10.002_bib41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2013.12.015","article-title":"A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: Modafinil, levodopa-carbidopa, naltrexone","volume":"136","author":"Schmitz","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.brat.2018.10.002_bib42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/10550490903077929","article-title":"High-dose naltrexone therapy for cocaine-alcohol dependence","volume":"18","author":"Schmitz","year":"2009","journal-title":"American Journal on Addictions"},{"issue":"3","key":"10.1016\/j.brat.2018.10.002_bib43","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/a0019195","article-title":"Contingency management and levodopa-carbidopa for cocaine treatment: A comparison of three behavioral targets","volume":"18","author":"Schmitz","year":"2010","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.brat.2018.10.002_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","article-title":"Levodopa pharmacotherapy for cocaine dependence: Choosing the optimal behavioral therapy platform","volume":"94","author":"Schmitz","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1176\/appi.ajp.162.2.340","article-title":"Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence","volume":"162","author":"Schottenfeld","year":"2005","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.brat.2018.10.002_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.03.010","article-title":"Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence","volume":"96","author":"Shoptaw","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.brat.2018.10.002_bib99","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2006.03.005","article-title":"Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence","volume":"85","author":"Shoptaw","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.brat.2018.10.002_bib47","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/add.13328","article-title":"Topiramate for cocaine dependence: A systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Singh","year":"2016","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.brat.2018.10.002_bib48","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2174\/1570159X13666150729222643","article-title":"The role of topiramate in the management of cocaine addiction: A possible therapeutic option","volume":"13","author":"Siniscalchi","year":"2015","journal-title":"Current Neuropharmacology"},{"issue":"6","key":"10.1016\/j.brat.2018.10.002_bib49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jamapsychiatry.2013.872","article-title":"A multisite, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of vigabatrin for treating cocaine dependence","volume":"70","author":"Somoza","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.brat.2018.10.002_bib50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drugalcdep.2009.07.009","article-title":"A randomized trial of contingency management for adolescent marijuana abuse and dependence","volume":"105","author":"Stanger","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl 1","key":"10.1016\/j.brat.2018.10.002_bib51","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.jsat.2009.12.010","article-title":"Motivational incentives research in the national drug abuse treatment clinical trials Network","volume":"38","author":"Stitzer","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/13651501.2012.667116","article-title":"A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis","volume":"17","author":"Sulaiman","year":"2013","journal-title":"International Journal of Psychiatry in Clinical Practice"},{"issue":"1","key":"10.1016\/j.brat.2018.10.002_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"Journal of Addictive Diseases"},{"issue":"3","key":"10.1016\/j.brat.2018.10.002_bib54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2009.10.011","article-title":"The endogenous opioid system: A common substrate in drug addiction","volume":"108","author":"Trigo","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.brat.2018.10.002_bib55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.drugalcdep.2014.03.033","article-title":"Topiramate for cocaine dependence during methadone maintenance treatment: A randomized controlled trial","volume":"140","author":"Umbricht","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.brat.2018.10.002_bib56","series-title":"World drug report 2017","author":"United Nations Office on Drugs and Crime","year":"2017"},{"issue":"5","key":"10.1016\/j.brat.2018.10.002_bib57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2174\/187152708786927868","article-title":"Glutamate: The new frontier in pharmacotherapy for cocaine addiction","volume":"7","author":"Uys","year":"2008","journal-title":"CNS & Neurological Disorders - Drug Targets"},{"issue":"2","key":"10.1016\/j.brat.2018.10.002_bib58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/syn.890140210","article-title":"Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers","volume":"14","author":"Volkow","year":"1993","journal-title":"Synapse"},{"issue":"1\u20133","key":"10.1016\/j.brat.2018.10.002_bib59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drugalcdep.2012.10.024","article-title":"Atomoxetine does not alter cocaine use in cocaine dependent individuals: Double blind randomized trial","volume":"130","author":"Walsh","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.brat.2018.10.002_bib60","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/7854_2015_374","article-title":"Motivation and contingency management treatments for substance use disorders","volume":"27","author":"Walter","year":"2016","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.brat.2018.10.002_bib61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2016.08.020","article-title":"Anhedonia is associated with poorer outcomes in contingency management for cocaine use disorder","volume":"72","author":"Wardle","year":"2017","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Behaviour Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005796718301566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005796718301566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T08:46:02Z","timestamp":1662194762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005796718301566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":62,"alternative-id":["S0005796718301566"],"URL":"https:\/\/doi.org\/10.1016\/j.brat.2018.10.002","relation":{},"ISSN":["0005-7967"],"issn-type":[{"value":"0005-7967","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review","name":"articletitle","label":"Article Title"},{"value":"Behaviour Research and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brat.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}